Harpoon Therapeutics, Inc. [HARP]

Source: 

Company Overview

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells.